Company Deep Dive

Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.

Request Deep Dive(50 Feathers)

600479.SS

STRONG BUYGet insider-trade alerts

ZhuZhou QianJin Pharmaceutical Co.,Ltd · Healthcare · China · $684M · Avg Vol: $7M/d

98
StockRank
Q
73
V
74
M
58
P/E (TTM)
13.7x
ROE
11.7%
D/E
0.0x
Dividend %
4.0%
Director Trades · 180d
None in 180d →
Buybacks · 180d
None in 180d →
Loading...
PRICE (1Y)-8.9%
1.391.431.461.491.53May 15Jun 5Jun 26
SMA 50SMA 200
Close
$1.39
RSI (14)
23.5
52W High
$1.70
From 52W High
0.8%

SCORE BREAKDOWN

Quality
73
ROIC
12.5%80.2
ROE
11.7%75.7
GP/Assets
35.6%75.1
Op. Margin
8.6%62.8
FCF/Assets
7.2%78.1
Piotroski
497.3
Int. Cover
50.0x88.5
D/E Ratio
0.02x83.7
Current Ratio
1.48x25.2
Value
74
P/E (TTM)
13.7x76.8
EV/EBITDA
9.6x68.7
P/FCF
13.0x74.5
P/B
1.5x69.4
P/S
1.3x77.8
Div Yield
4.0%81.2
Momentum
58
52W High %
82%74.6
RS 6M
-14%59.7
SMA 50/200
0.97x55.9
EPS Rev 4W
—N/A
EPS Rev 12W
—N/A
EPS Improve
—N/A
Q Growth
41%72.4

FUNDAMENTALS

Market Cap
$684M
P/E (Forward)
—
Gross Margin
49.1%

SECTOR PEERS

Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of 600479.SS are excluded.

TickerCompanyMkt CapStockRankSignal
600479.SSZhuZhou QianJin Pharmaceutical Co.,Ltd(you)$684M98STRONG BUY
2877.HKChina Shineway Pharmaceutical Group Limited$716M100STRONG BUY
600351.SSYabao Pharmaceutical Group Co., Ltd$581M99STRONG BUY
9989.HKShenzhen Hepalink Pharmaceutical Group Co., Ltd.$717M95STRONG BUY
000915.SZShandong Wit Dyne Health Co.,Ltd.$932M97STRONG BUY
002393.SZTianjin Lisheng Pharmaceutical Co.,Ltd.$630M92STRONG BUY
000650.SZRenhe Pharmacy Co.,Ltd$1.0B97STRONG BUY
002275.SZGuilin Sanjin Pharmaceutical Co., Ltd.$1.0B96STRONG BUY
002390.SZGuizhou Xinbang Pharmaceutical Co., Ltd.$744M86STRONG BUY
600976.SSJianmin Pharmaceutical Group Co.,Ltd.$585M87STRONG BUY

Peer medians: ROE 4.8% · P/E 26.5x · Gross margin 52.5%

ZhuZhou QianJin Pharmaceutical Co.,Ltd (600479.SS) — Stock Score Summary

ZhuZhou QianJin Pharmaceutical Co.,Ltd (600479.SS) has a MoatMap StockRank of 98/100 based on Quality (73/100), Value (74/100), and Momentum (58/100) factor scores. The current signal is STRONG BUY.

Key Financial Metrics

Price$1.39
Market Cap$684M
P/E (TTM)13.67
Price/Book1.50
Return on Equity11.7%
Return on Invested Capital12.5%
Debt/Equity1.81
Gross Margin49.1%
Operating Margin8.6%
Revenue Growth-3.5%
Dividend Yield4.0%
Free Cash Flow$52M

ZhuZhou QianJin Pharmaceutical Co.,Ltd operates in the Drug Manufacturers - Specialty & Generic industry, part of the Healthcare sector (China).

Frequently Asked Questions

What is ZhuZhou QianJin Pharmaceutical Co.,Ltd’s (600479.SS) StockRank?
MoatMap’s StockRank for ZhuZhou QianJin Pharmaceutical Co.,Ltd (600479.SS) is 98/100, with a Strong Buy signal. It is a composite of Quality (73), Value (74), and Momentum (58) factor ranks across MoatMap’s 20,000+ stock universe.
Does ZhuZhou QianJin Pharmaceutical Co.,Ltd have an economic moat?
ZhuZhou QianJin Pharmaceutical Co.,Ltd (600479.SS) has a Quality factor score of 73/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is ZhuZhou QianJin Pharmaceutical Co.,Ltd a buy, hold, or sell?
MoatMap’s current signal for ZhuZhou QianJin Pharmaceutical Co.,Ltd (600479.SS) is Strong Buy, based on a StockRank of 98/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is ZhuZhou QianJin Pharmaceutical Co.,Ltd in?
ZhuZhou QianJin Pharmaceutical Co.,Ltd (600479.SS) operates in the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry (China).
Browse all ranked stocks600479.SS deep dive reportAI ChampionsHow we score stocksSense-check another stock